The Incidentalome
- 12 July 2006
- journal article
- editorial
- Published by American Medical Association (AMA) in Jama-Journal Of The American Medical Association
- Vol. 296 (2), 212-215
- https://doi.org/10.1001/jama.296.2.212
Abstract
Genomic medicine is poised to offer a broad array of new genome-scale screening tests. However, these tests may lead to a phenomenon in which multiple abnormal genomic findings are discovered, analogous to the “incidentalomas” that are often discovered in radiological studies. If practitioners pursue these unexpected genomic findings without thought, there may be disastrous consequences. First, physicians will be overwhelmed by the complexity of pursuing unexpected genomic measurements. Second, patients will be subjected to unnecessary follow-up tests, causing additional morbidity. Third, the cost of genomic medicine will increase substantially with little benefit to patients or physicians (but with great financial benefits to the genomic testing industry), thus throwing the overall societal benefit of genome-based medicine into question. In this article, we discuss the basis for these concerns and suggest several steps that can be taken to help avoid these substantive risks to the practice of genomically personalized medicine.This publication has 15 references indexed in Scilit:
- Incidental Findings in Brain Imaging ResearchScience, 2006
- Optimal Selection of Individuals for BRCA Mutation Testing: A Comparison of Available MethodsJournal of Clinical Oncology, 2006
- Microarray data analysis: from disarray to consolidation and consensusNature Reviews Genetics, 2006
- Altered Gene Expression Profiles Reveal Similarities and Differences Between Parkinson Disease and Model SystemsThe Neuroscientist, 2005
- Power tools for human geneticsNature Genetics, 2005
- Newborn screening for cystic fibrosis in Wisconsin: nine-year experience with routine trypsinogen/DNA testingThe Journal of Pediatrics, 2005
- Genomic Assessment of Pediatric Acute LeukemiaThe Cancer Journal, 2005
- Bayesian Analysis and Risk Assessment in Genetic Counseling and TestingThe Journal of Molecular Diagnostics, 2004
- Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression MonitoringScience, 1999
- Discovery and analysis of inflammatory disease-related genes using cDNA microarraysProceedings of the National Academy of Sciences of the United States of America, 1997